In a recent study published in Nature Communications, researchers described the detection of a human interleukin-1β (hIL-1β) antagonist with low molecular weight (LMW) that disrupts interactions with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback